Synthesis and α-adrenergic binding ligand affinities of 2- iminoimidazolidine derivatives

Chemical and Pharmaceutical Bulletin

Volumn 48, Issue 5, 2000, Pages 729-733

  Chang Fong, Jean ^a   Benamour, Khalid ^a   Szymonski, Barbara ^a   Thomasson, François ^a   Morand, Jean Marc ^a   Cussac, Max ^a  

^a Laboratoire de Pharmacochimie   (France)

Author keywords

Adrenergic 2 ligand; Imidazolidine derivative; Veinotonic agent

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 (4 METHYL 2 OXO 2H BENZOPYRAN 3 YL)IMINOIMIDAZOLIDINE; 2 IMIDAZOLINE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; IDAZOXAN; MOXONIDINE; PRAZOSIN; RAUWOLSCINE; RILMENIDINE; TRITIUM; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; LIGAND BINDING; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0034125587     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.48.729     Document Type: Article

References (36)

1. McGrath J. C., Brown C. M., Wilson V. G., Med. Res. Rev., 9, 506-507 (1989).
2. Flavahan N. A., Rimele T. J., Cooke J. P., Vanhoutte P. M., J. Pharmacol. Exp. Ther., 230, 699-705 (1984).
3. Daly C., Mc Grath J., Wilson V, Brit. J. Pharmacol., 94, 1085-1090 (1988).
4. Noack T., Edwards G., Deitmer P., Greengrass P., Morita T., Andersson P. O., Criddle D., Wyllie M. G., Weston A. H., Brit. J. Pharmacol., 106, 17-24 (1992).
5. Schwietert R., Wilhem D., Wilffert B., van Zwieten P. A., Eur. J. Pharmacol., 211, 87-95 (1992).
6. McPherson G. A., Angus J. A., Brit. J. Pharmacol., 97, 941-949 (1989).
7. Ibbotson T., Edwards G., Weston A. H., Brit. J. Pharmacol., 110, 1556-1564 (1993).
8. Rouot B., Lederc G., Wermuth C. G., Eur. J Med. Chem., 5, 545-551 (1973).
9. Rouot B., Leclerc G., Wermuth C. G., Miesch F., Schwartz J., J. Med. Chem., 19, 1049-1054 (1976).
10. Timmermans P. B. M. W. M., Van Zwieten P. A., J. Med. Chem., 20, 1636-1644 (1977).
11. Timmermans P. B. M. W. M., Hoefke W., Stähle H., Van Zwieten P. A., Progr. Pharmacol., 3, 1-104 (1980).
12. Reuter H. D., "Les Phytomédicaments Vaso-actifs, in Phytothérapie, aromatotherapie," Vol. 9 ed. by Editions Techniques, Encycl. Méd. Nat., Paris, 1991, D-5, 24 p.
13. 10, p. 14.
14. Bruneton J., Flavonoïdes, ̈Pharmacognosie, Phytochimie, Plantes Médicinales,̈ 2nd ed., ed. by Tech. Doc., Paris, 1997, pp. 265-300.
15. Aspinall S. R., Bianco E. J., J. Am. Chem. Soc., 73, 602-603 (1951).
16. Najer H., Guidicelli R., Sette J., Bull. Soc. Chim. France, 1961, 2114-2116.
17. Chapleo C. B., Butter R. C. M., England D. C., Myers P. L., Roach A. G., Smith C. F. C., Stillings M. R., Tulloch I. F., J. Med. Chem., 32, 1627-1630 (1989).
18. Roberts J. G., J. Chem. Soc., 1964, 176-178.
19. Nathanson J. A., Kaugars G., J. Med. Chem., 32, 1795-1799 (1989).
20. Chakravarty D., Dutta S. P., Mitra A. K., Current Sci., 34, 177-179 (1965).
21. Chakravarty D., Das R., J. Indian Chem. Soc., 48, 371-374 (1971).
22. Tripathy P. K., Mukerjee A. K., Heterocycles, 26, 1517-1520 (1987).
23. Becket G. J. P., Ellis G. P., Tetrahedron Lett., 1976, 719-720.
24. Tanaka M., Murakami Y., Morita H., Takagi K., Chem. Pharm. Bull., 33, 2129-2132 (1985).
25. Huebner C. F., Link K. P., J. Am. Chem. Soc., 67, 99-102 (1945).
26. Oyamada T., Fukawa T., J. Chem. Soc. Jpn.,64, 1163-1166 (1943).
27. Shimizu M., Nakazawa S., J. Chem. Soc. Jpn., 73, 522-523 (1953).
28. Strader C., Fong T., Tota M., Underwood D., Dixon R., Annu. Rev. Biochem., 63, 101-134 (1994).
29. Guicheney P., Dausse J.-R, Meyer P., J. Pharmacol. (Paris), 12, 255-262 (1981).
30. Leo A., Chem. Rev., 93, 1281-1306 (1993).
31. Ghose A., Crippen G., J. Comp. Chem., 7, 565-577 (1986).
32. Laboratoire Lafon., Belg. Pat. 812,749 (Cl. C 07 d) (15 Jul 1974)8 p.
33. Moret C., Charveron M., Finberg J. P. M., Couzinier J. P., Briley M., Neuropharmacol., 24, 1211-1219 (1985).
34. Diop L., Dausse J. P., Meyer P., J. Neurochem., 41, 710-715(1983).
35. Uhlen S., Wikberg J. E., Pharmacol. Toxicol., 69, 341-350 (1991).
36. Greengrass P., Bremner R., Eur. J. Pharmacol., 55, 323-326 (1979).